openPR Logo
Press release

2025-2034 Artificial Intelligence In Cancer Diagnostics Market Evolution: Disruptions, Innovations, and Untapped Opportunities

10-16-2025 07:43 AM CET | IT, New Media & Software

Press release from: The Business Research Company

Artificial Intelligence In Cancer Diagnostics

Artificial Intelligence In Cancer Diagnostics

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts._x000D_
_x000D_
What Is the Expected CAGR for the Artificial Intelligence In Cancer Diagnostics Market Through 2025?_x000D_
The market size of artificial intelligence in cancer diagnostics has experienced prolific growth in the recent past. Projections show it will escalate from $0.39 billion in 2024 to $0.52 billion in 2025, representing a compound annual growth rate (CAGR) of 32.6%. The substantial growth in the historic period could be credited to factors such as a rise in cancer cases, accessibility of big data, the emergence of individualized oncology, initiatives in precision medicine, and the incorporation of genomic data._x000D_
_x000D_
What's the Projected Size of the Global Artificial Intelligence In Cancer Diagnostics Market by 2029?_x000D_
In the forthcoming years, the market size for artificial intelligence in cancer diagnostics is predicted to undergo substantial expansion. It is expected to reach $1.54 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 31.1%. This projected growth during the forecast period can be linked to several factors including a shortage of clinicians, an aging population, the worldwide adoption of telemedicine, the merging of AI with electronic health records, and an increase in cancer screening programs. The forecast period will also witness significant trends such as rapid progress in AI algorithms, improvements in imaging technology, technological breakthroughs in pathology, forward strides in radiomics and radiogenomics, drug evolution, deep learning, and the use of AI for predictive biomarker discovery._x000D_
_x000D_
View the full report here: _x000D_
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-cancer-diagnostics-global-market-report_x000D_
_x000D_
Top Growth Drivers in the Artificial Intelligence In Cancer Diagnostics Industry: What's Accelerating the Market? _x000D_
The escalating occurrence of cancer will likely drive the expansion of artificial intelligence in the cancer diagnostics market. Cancer is characterized by unregulated cell growth, affecting multiple organs and causing significant global morbidity and mortality. In the realm of cancer diagnostics, artificial intelligence is employed for the precise and efficient analysis of medical imaging data, which aids in early detection and precise categorization of cancerous growths. For example, the World Health Organization, a Switzerland-based international entity, reported in February 2024 that approximately 20 million fresh cancer cases were identified in 2022, resulting in 9.7 million fatalities. It is estimated that about 53.5 million people were alive within five years after their cancer diagnosis. As a result, the escalating occurrence of cancer is predicted to drive the expansion of artificial intelligence in the cancer diagnostics market._x000D_
_x000D_
Get your free sample here:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=12685&type=smp_x000D_
_x000D_
What Trends Will Shape the Artificial Intelligence In Cancer Diagnostics Market Through 2029 and Beyond?_x000D_
The surge in technological advancements is a notable trend escalating in the realm of AI in the cancer diagnostics market. Noteworthy corporations in the market are focused on developing groundbreaking instruments for diverse cancer conditions to maintain their market standing. For instance, Qritive, a firm based in Singapore that offers AI-driven solutions to assist pathologists, introduced QAi Prostate in March 2023. This novel AI-empowered instrument facilitates diagnosis of prostate cancer. It can precisely detect areas of prostatic adenocarcinoma and distinguish between malignant and benign tumor zones in biopsy tissue examples. This tool delivers a comprehensive breakdown of tumor dimensions and percentages for each slide or area of particular interest (ROI), enabling pathologists to make well-informed decisions rapidly._x000D_
_x000D_
What Are the Main Segments in the Artificial Intelligence In Cancer Diagnostics Market?_x000D_
The artificial intelligence in cancer diagnosticsmarket covered in this report is segmented - _x000D_
_x000D_
1) By Component: Software Solutions, Hardware, Services_x000D_
2) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Types_x000D_
3) By Application: Screening And Diagnosis, Tumor Identification, Surveillance, Treatment_x000D_
4) By End-User: Hospitals, Medical Research Institute, Diagnostic Centers, Contract Research Organization_x000D_
_x000D_
Subsegments:_x000D_
1) By Software Solutions: Imaging Analysis Software, Predictive Analytics Software, Decision Support Systems, Data Management Platforms _x000D_
2) By Hardware: Imaging Devices, Biomarkers Detection Equipment, Computing Infrastructure _x000D_
3) By Services: Consulting Services, Implementation Services, Maintenance And Support Services, Training Services _x000D_
_x000D_
Tailor your insights and customize the full report here:_x000D_
https://www.thebusinessresearchcompany.com/customise?id=12685&type=smp_x000D_
_x000D_
Which Top Companies are Driving Growth in the Artificial Intelligence In Cancer Diagnostics Market?_x000D_
Major companies operating in the artificial intelligence in cancer diagnostics market include Microsoft Corporation, Pfizer Inc., Johnson & Johnson's, Siemens, Roche Holding AG, Google LCC, International Business Machines Corporation, Thermo Fisher Scientific Inc., Oracle Corporation, GE Healthcare, Illumina Inc., Bio Rad Laboratories Inc., Flatiron Health, Tempus Labs Inc., Paige AI Inc., OncoHealth Corporation, Path AI Inc., Aidoc, Sophia Genetics SA, Digital Diagnostics Inc., Prognos Health, Aidence, Kheiron Medical Technologies Limited, Zebra Medical Vision, Niramai, Enlitic Inc., Therapixel, Medial EarlySign Ltd., Freenome, SkinVision B.V. _x000D_
_x000D_
Which Regions Will Dominate the Artificial Intelligence In Cancer Diagnostics Market Through 2029?_x000D_
North America was the largest region in the artificial intelligence in cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_
_x000D_
Purchase the full report today:_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12685_x000D_
_x000D_
This Report Supports:_x000D_
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions._x000D_
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning._x000D_
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks._x000D_
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work._x000D_
_x000D_
Learn More About The Business Research Company_x000D_
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead. _x000D_
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making._x000D_
_x000D_
Reach out to us:_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Europe +44 7882 955267_x000D_
Asia & Others +44 7882 955267 & +91 8897263534_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
Follow Us On:_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company _x000D_
Twitter: https://twitter.com/tbrc_info _x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 2025-2034 Artificial Intelligence In Cancer Diagnostics Market Evolution: Disruptions, Innovations, and Untapped Opportunities here

News-ID: 4226426 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For